Medical Journals

A Comparison of Fenoldopam with Dopamine and Sodium Nitroprusside in Patients Undergoing Cross-clamping of the Abdominal Aorta.

Authors:
  • Oliver William C
  • Nuttall Gregory A
  • Cherry Kenneth J
  • Decker Paul A
  • Bower Thomas
  • Ereth Mark H

From: Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. oliver.william@mayo.edu

Anesthesia and analgesia

  • Publish Date: Oct 2006
  • ISSN: 1526-7598
  • Volume: 103
  • Issue: 4
  • Pages: 833-40
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Oliver William C, Nuttall Gregory A, Cherry Kenneth J, et al. A Comparison of Fenoldopam with Dopamine and Sodium Nitroprusside in Patients Undergoing Cross-clamping of the Abdominal Aorta.. Anesth. Analg. Oct 2006;103:833-40

Abstract

Fenoldopam, a selective dopamine-1-receptor agonist, decreases arterial blood pressure rapidly, with a brief duration of action similar to sodium nitroprusside (SNP), but in contrast to SNP, it increases renal blood flow. We compared the hemodynamic and renal effects of fenoldopam in patients undergoing abdominal aortic surgery requiring cross-clamping of the aorta with another therapeutic option, dopamine and SNP. Fenoldopam or 2 mcg x kg(-1) x min(-1) of dopamine and SNP was infused before incision in 60 randomly selected patients in a double-blind fashion. Hemodynamic variables were recorded before incision, immediately before clamping the aorta, 5 min after cross-clamp release and upon completion of surgery. Urine output, serum creatinine, and creatinine clearance were measured intraoperatively and postoperatively. Characteristics were compared between groups using two-sample rank sum test for continuous variables and Fisher’s exact test for discrete variables. The occurrence of severe hypotension, maximum systolic blood pressure, and need for additional antihypertensive drugs were not different between the groups. Most intraoperative hemodynamic variables and all indices of renal function did not differ according to treatment. Therefore, fenoldopam has no therapeutic advantage compared with similar therapies in patients undergoing major vascular surgery involving cross-clamping of the aorta.

Mesh Headings (Keywords): Aged, Aged, 80 and over, Anesthesia, Antihypertensive Agents, Aorta, Abdominal, Blood Pressure, Dopamine, Double-Blind Method, Female, Fenoldopam, Heart Rate, Humans, Kidney, Male, Middle Aged, Nitroprusside, Vascular Surgical Procedures


Check for Full Text / PubMed Unique Identifier (PMID): 17000789


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.